Fig. 5From: Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicityCell viability after treatment with free liposomal NPs and chitosomes nano-formulation (a), and following treatment with rosuvastatin loaded liposomal NPs and chitosomes nano-formulation (b)Back to article page